• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3-芳基-1-苯基-1H-吡唑衍生物作为新型多靶点导向配体用于治疗阿尔茨海默病,具有乙酰胆碱酯酶和单胺氧化酶抑制特性。

3-Aryl-1-phenyl-1H-pyrazole derivatives as new multitarget directed ligands for the treatment of Alzheimer's disease, with acetylcholinesterase and monoamine oxidase inhibitory properties.

作者信息

Kumar Ashwani, Jain Sandeep, Parle Milind, Jain Neelam, Kumar Parvin

机构信息

Drug Discovery and Research Laboratory, Department of Pharmaceutical Sciences,Guru Jambheshwar University of Science and Technology, Hisar -125 001, Haryana, India.

Department of Pharmaceutical Education and Research, BPSMV, Khanpur kalan, Sonepat, Haryana, India.

出版信息

EXCLI J. 2013 Dec 13;12:1030-42. eCollection 2013.

PMID:27298613
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4904743/
Abstract

A series of 3-aryl-1-phenyl-1H-pyrazole derivatives was synthesized in good yield and assayed in vitro as inhibitors of the mice acetylcholinesterase (AChE) and two goat liver monoamine oxidase (MAO) isoforms, MAO-A and MAO-B. Most of the compounds demonstrated a good AChE and selective MAO-B inhibitory activities in the nanomolar or low micromolar range. N-((3-(4-chlorophenyl)-1-phenyl-1H-pyrazole-4-yl) methylene) benzenamine (3e, pIC50 = 4.2) and N-((4-fluorophenyl)-1-phenyl-1H-pyrazole-4-yl) methylene) methanamine (3f, pIC50 = 3.47) were the most potent AChE and highly selective MAO-B inhibitors respectively. Structure activity relationships showed that chloro derivatives were more effective AChE inhibitors as compared to fluoro derivatives while reverse trend was observed in MAO-B inhibitory activity. With the aid of modeling studies, potential binding orientations as well as interactions of the compounds in the AChE and MAO-B active sites were examined.

摘要

合成了一系列3-芳基-1-苯基-1H-吡唑衍生物,产率良好,并作为小鼠乙酰胆碱酯酶(AChE)和两种山羊肝脏单胺氧化酶(MAO)同工型MAO-A和MAO-B的抑制剂进行了体外测定。大多数化合物在纳摩尔或低微摩尔范围内表现出良好的AChE和选择性MAO-B抑制活性。N-((3-(4-氯苯基)-1-苯基-1H-吡唑-4-基)亚甲基)苯胺(3e,pIC50 = 4.2)和N-((4-氟苯基)-1-苯基-1H-吡唑-4-基)亚甲基)甲胺(3f,pIC50 = 3.47)分别是最有效的AChE和高选择性MAO-B抑制剂。构效关系表明,与氟代衍生物相比,氯代衍生物是更有效的AChE抑制剂,而在MAO-B抑制活性方面观察到相反的趋势。借助建模研究,研究了化合物在AChE和MAO-B活性位点的潜在结合取向以及相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad6d/4904743/93488166387b/EXCLI-12-1030-g-005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad6d/4904743/435dd936f117/EXCLI-12-1030-t-001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad6d/4904743/f74deee5e548/EXCLI-12-1030-t-002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad6d/4904743/0ae68a378af8/EXCLI-12-1030-t-003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad6d/4904743/745bf10e77dc/EXCLI-12-1030-g-001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad6d/4904743/ddfc0e57d8a7/EXCLI-12-1030-g-002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad6d/4904743/fc507086cb7f/EXCLI-12-1030-g-003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad6d/4904743/175ae6e36f5e/EXCLI-12-1030-g-004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad6d/4904743/93488166387b/EXCLI-12-1030-g-005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad6d/4904743/435dd936f117/EXCLI-12-1030-t-001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad6d/4904743/f74deee5e548/EXCLI-12-1030-t-002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad6d/4904743/0ae68a378af8/EXCLI-12-1030-t-003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad6d/4904743/745bf10e77dc/EXCLI-12-1030-g-001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad6d/4904743/ddfc0e57d8a7/EXCLI-12-1030-g-002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad6d/4904743/fc507086cb7f/EXCLI-12-1030-g-003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad6d/4904743/175ae6e36f5e/EXCLI-12-1030-g-004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad6d/4904743/93488166387b/EXCLI-12-1030-g-005.jpg

相似文献

1
3-Aryl-1-phenyl-1H-pyrazole derivatives as new multitarget directed ligands for the treatment of Alzheimer's disease, with acetylcholinesterase and monoamine oxidase inhibitory properties.3-芳基-1-苯基-1H-吡唑衍生物作为新型多靶点导向配体用于治疗阿尔茨海默病,具有乙酰胆碱酯酶和单胺氧化酶抑制特性。
EXCLI J. 2013 Dec 13;12:1030-42. eCollection 2013.
2
Synthesis and monoamine oxidase inhibitory activities of some 3-(4-fluorophenyl)-5-aryl-n-substituted-4,5-dihydro-(1H)-pyrazole-1-carbothioamide derivatives.某些3-(4-氟苯基)-5-芳基-N-取代-4,5-二氢-(1H)-吡唑-1-碳硫酰胺衍生物的合成及单胺氧化酶抑制活性
Drug Res (Stuttg). 2014 Nov;64(11):591-8. doi: 10.1055/s-0033-1363997. Epub 2014 Jan 22.
3
4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.4,6-二苯基嘧啶衍生物作为单胺氧化酶和乙酰胆碱酯酶的双重抑制剂用于治疗阿尔茨海默病。
ACS Chem Neurosci. 2019 Jan 16;10(1):252-265. doi: 10.1021/acschemneuro.8b00220. Epub 2018 Oct 22.
4
Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease.源自羟基氨基茚和苯乙胺的新型乙酰胆碱酯酶和单胺氧化酶双重抑制剂作为阿尔茨海默病的潜在治疗药物
J Med Chem. 2002 Nov 21;45(24):5260-79. doi: 10.1021/jm020120c.
5
Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase A inhibitors.1,3,5-三取代-4,5-二氢-(1H)-吡唑衍生物作为强效且高度选择性单胺氧化酶A抑制剂的合成、生物学评价及三维定量构效关系研究
Curr Med Chem. 2006;13(12):1411-28. doi: 10.2174/092986706776872907.
6
Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site.2-氨基-5-硝基噻唑衍生的氨基脲作为单胺氧化酶和胆碱酯酶双重抑制剂的设计、合成及药理评价:芳基结合位点大小的影响
J Enzyme Inhib Med Chem. 2018 Dec;33(1):37-57. doi: 10.1080/14756366.2017.1389920.
7
Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole derivatives.1-硫代氨基甲酰基-3,5-二芳基-4,5-二氢-(1H)-吡唑衍生物的合成、分子模拟研究及其对单胺氧化酶的选择性抑制活性
J Med Chem. 2005 Nov 17;48(23):7113-22. doi: 10.1021/jm040903t.
8
Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives.N1-硫代碳酰胺基-3,5-二(杂)芳基-4,5-二氢-(1H)-吡唑衍生物的合成及其对人单胺氧化酶的抑制活性。
Eur J Med Chem. 2010 Feb;45(2):800-4. doi: 10.1016/j.ejmech.2009.11.003. Epub 2009 Nov 6.
9
Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase.1-乙酰基-3,5-二苯基-4,5-二氢-(1H)-吡唑衍生物对单胺氧化酶的合成及选择性抑制活性
J Med Chem. 2004 Apr 8;47(8):2071-4. doi: 10.1021/jm031042b.
10
Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives.N1-丙酰基-3,5-二苯基-4,5-二氢-(1H)-吡唑衍生物的合成、分子建模研究及其对单胺氧化酶的选择性抑制活性
Eur J Med Chem. 2008 Oct;43(10):2262-7. doi: 10.1016/j.ejmech.2007.12.026. Epub 2008 Jan 6.

引用本文的文献

1
Exploring the Potential Biological Activities of Pyrazole-Based Schiff Bases as Anti-Diabetic, Anti-Alzheimer's, Anti-Inflammatory, and Cytotoxic Agents: Studies with Computational Predictions.探索吡唑基席夫碱作为抗糖尿病、抗阿尔茨海默病、抗炎和细胞毒性剂的潜在生物活性:计算预测研究
Pharmaceuticals (Basel). 2024 May 17;17(5):655. doi: 10.3390/ph17050655.
2
Effects of Linkers and Substitutions on Multitarget Directed Ligands for Alzheimer's Diseases: Emerging Paradigms and Strategies.连接子和取代基对阿尔茨海默病多靶标导向配体的影响:新兴范例和策略。
Int J Mol Sci. 2022 May 29;23(11):6085. doi: 10.3390/ijms23116085.
3

本文引用的文献

1
Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.设计、合成及评价新型他克林-香豆素杂合体作为多功能乙酰胆碱酯酶抑制剂用于治疗阿尔茨海默病。
Eur J Med Chem. 2013 Jun;64:540-53. doi: 10.1016/j.ejmech.2013.03.051. Epub 2013 Apr 6.
2
Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.设计、合成及黄酮衍生物作为潜在的多功能乙酰胆碱酯酶抑制剂对阿尔茨海默病的评价。
Bioorg Med Chem Lett. 2013 May 1;23(9):2636-41. doi: 10.1016/j.bmcl.2013.02.095. Epub 2013 Mar 1.
3
Synthesis, preclinical evaluation and antidepressant activity of 5-substituted phenyl-3-(thiophen-2-yl)-4, 5-dihydro-1H-pyrazole-1-carbothioamides.
5-取代苯基-3-(噻吩-2-基)-4,5-二氢-1H-吡唑-1-碳硫酰胺的合成、临床前评价及抗抑郁活性
EXCLI J. 2014 Apr 29;13:437-45. eCollection 2014.
Synthesis of tacrine-lophine hybrids via one-pot four component reaction and biological evaluation as acetyl- and butyrylcholinesterase inhibitors.
通过一锅四组分反应合成他克林-洛啡烷杂合体,并作为乙酰胆碱酯酶和丁酰胆碱酯酶抑制剂进行生物评价。
Eur J Med Chem. 2013 Apr;62:556-63. doi: 10.1016/j.ejmech.2013.01.029. Epub 2013 Feb 4.
4
Inhibition of monoamine oxidase by phthalide analogues.邻苯二甲酸酐类似物对单胺氧化酶的抑制作用。
Bioorg Med Chem Lett. 2013 Mar 1;23(5):1269-73. doi: 10.1016/j.bmcl.2013.01.003. Epub 2013 Jan 11.
5
Indole alkaloids of Psychotria as multifunctional cholinesterases and monoamine oxidases inhibitors.益智属吲哚生物碱作为多功能乙酰胆碱酯酶和单胺氧化酶抑制剂。
Phytochemistry. 2013 Feb;86:8-20. doi: 10.1016/j.phytochem.2012.11.015. Epub 2012 Dec 19.
6
Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.多奈哌齐和 N-[(5-(苄氧基)-1-甲基-1H-吲哚-2-基)甲基]-N-甲基丙-2-炔-1-胺杂合体的合成、生物评价和分子模拟作为治疗阿尔茨海默病的新型多效胆碱酯酶/单胺氧化酶抑制剂。
J Med Chem. 2011 Dec 22;54(24):8251-70. doi: 10.1021/jm200853t. Epub 2011 Nov 15.
7
Synthesis and biological evaluation of novel pyrazolyl-2,4-thiazolidinediones as anti-inflammatory and neuroprotective agents.新型吡唑基-2,4-噻唑烷二酮类化合物的合成及抗炎和神经保护活性评价。
Bioorg Med Chem. 2010 Mar 1;18(5):2019-28. doi: 10.1016/j.bmc.2010.01.021. Epub 2010 Jan 15.
8
AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.AutoDock Vina:通过新的评分函数、高效优化和多线程改进对接的速度和准确性。
J Comput Chem. 2010 Jan 30;31(2):455-61. doi: 10.1002/jcc.21334.
9
MTDL design strategy in the context of Alzheimer's disease: from lipocrine to memoquin and beyond.阿尔茨海默病背景下的MTDL设计策略:从脂分泌到美金刚胺及其他。
Curr Pharm Des. 2009;15(6):601-13. doi: 10.2174/138161209787315585.
10
Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets.神经精神疾病中的认知功能障碍:选定的血清素受体亚型作为治疗靶点。
Behav Brain Res. 2008 Dec 16;195(1):30-8. doi: 10.1016/j.bbr.2007.12.006. Epub 2008 Feb 1.